Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes
Clinical trial NCT00575874 · COMPLETED
Trial details
- NCT number
- NCT00575874
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-06-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.